1
|
Jauhola O, Ronkainen J, Koskimies O,
Ala-Houhala M, Arikoski P, Hölttä T, Jahnukainen T, Rajantie J,
Ormälä T and Nuutinen M: Clinical course of extrarenal symptoms in
Henoch-Schonlein purpura: A 6-month prospective study. Arch Dis
Child. 95:871–876. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Punnoose AR, Lynm C and Golub RM: JAMA
patient page. Henoch-Schönlein purpura. JAMA. 307:7422012.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Kawasaki T and Kawai T: Toll-like receptor
signaling pathways. Front Immunol. 5:4612014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Miranda-Hernandez S and Baxter AG: Role of
toll-like receptors in multiple sclerosis. Am J Clin Exp Immunol.
2:75–93. 2013.PubMed/NCBI
|
5
|
Klaassen EM, van de Kant KD, Soeteman M,
Damoiseaux J, van Eys G, Stobberingh EE, Stelma FF, Quaak M, van
Schayck OC, Jöbsis Q, et al: CD14/Toll-like receptors interact with
bacteria and regulatory T-cells in the development of childhood
asthma. Eur Respir J. 44:799–802. 2014. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kirchner M, Sonnenschein A, Schoofs S,
Schmidtke P, Umlauf VN and Mannhardt-Laakmann W: Surface expression
and genotypes of toll-like receptors 2 and 4 in patients with
juvenile idiopathic arthritis and systemic lupus erythematosus.
Pediatr Rheumatol Online J. 11:92013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Lin IC, Kuo HC, Lin YJ, Wang FS, Wang L,
Huang SC, Chien SJ, Huang CF, Wang CL, Yu HR, et al: Augmented TLR2
expression on monocytes in both human Kawasaki disease and a mouse
model of coronary arteritis. PLoS One. 7:e386352012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wang H, Gou SJ, Zhao MH and Chen M: The
expression of Toll-like receptors 2, 4 and 9 in kidneys of patients
with anti-neutrophil cytoplasmic antibody (ANCA)-associated
vasculitis. Clin Exp Immunol. 177:603–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
Na SY, Park MJ, Park S and Lee ES:
Up-regulation of Th17 and related cytokines in Behçet's disease
corresponding to disease activity. Clin Exp Rheumatol. 31:32–40.
2013.PubMed/NCBI
|
10
|
Kato H and Perl A: Mechanistic target of
rapamycin complex 1 expands Th17 and
IL-4+CD4−CD8− double-negative T
cells and contracts regulatory T cells in systemic lupus
erythematosus. J Immunol. 192:4134–4144. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Park SJ and Shin JI: Another beneficial
effect of rituximab on refractory ANCA-associated vasculitis: The
role of interleukin-17 suppression? Scand J Immunol. 77:2212013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Li YY, Li CR, Wang GB, Yang J and Zu Y:
Investigation of the change in CD4+ T cell subset in
children with Henoch-Schonlein purpura. Rheumatol Int.
32:3785–3792. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jen HY, Chuang YH, Lin SC, Chiang BL and
Yang YH: Increased serum interleukin-17 and peripheral Th17 cells
in children with acute Henoch-Schönlein purpura. Pediatr Allergy
Immunol. 22:862–868. 2011. View Article : Google Scholar : PubMed/NCBI
|
14
|
Chen O, Zhu XB, Ren H, Wang YB and Sun R:
The imbalance of Th17/Treg in Chinese children with
Henoch-Schonlein purpura. Int Immunopharmacol. 16:67–71. 2013.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Donadio ME, Loiacono E, Peruzzi L, Amore
A, Camilla R, Chiale F, Vergano L, Boido A, Conrieri M, Bianciotto
M, et al: Toll-like receptors, immunoproteasome and regulatory T
cells in children with Henoch-Schönlein purpura and primary IgA
nephropathy. Pediatr Nephrol. 29:1545–1551. 2014. View Article : Google Scholar : PubMed/NCBI
|
16
|
Akira S: Mammalian Toll-like receptors.
Curr Opin Immunol. 15:5–11. 2003. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kogut MH, Iqbal M, He H, Philbin V, Kaiser
P and Smith A: Expression and function of Toll-like receptors in
chicken heterophils. Dev Comp Immunol. 29:791–807. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Chang H, Zhang QY, Cheng N, Zhang SQ and
Lin Y: Study on expression of TLR2 and TLR4 in peripheral blood
mononuclear cells and their relationship with Th1/Th2 immune
resposnse in patients with Henoch-Schonlein pupra. Zhong Hua Wei
Sheng Wu Xue He Mian Yi Xue Za Zhi. 33:839–844. 2013.(In
Chinese).
|
19
|
Ozen S, Ruperto N, Dillon MJ, Bagga A,
Barron K, Davin JC, Kawasaki T, Lindsley C, Petty RE, et al:
EULAR/PReS endorsed consensus criteria for the classification of
childhood vasculitides. Ann Rheum Dis. 65:936–941. 2006. View Article : Google Scholar : PubMed/NCBI
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Raphael I, Nalawade S, Eager TN and
Forsthuber TG: T cell subsets and their signature cytokines in
autoimmune and inflammatory diseases. Cytokine. 74:5–17. 2015.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Song X, Gao H and Qian Y: Th17
differentiation and their pro-inflammation function. Adv Exp Med
Biol. 841:99–151. 2014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Brown J, Wang H, Hajishengallis GN and
Martin M: TLR-signaling networks: An integration of adaptor
molecules, kinases and cross-talk. J Dent Res. 90:417–427. 2011.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Jin B, Sun T, Yu XH, Yang YX and Yeo AE:
The effects of TLR activation on T-cell development and
differentiation. Clin Dev Immunol. 2012:8364852012. View Article : Google Scholar : PubMed/NCBI
|
25
|
Qian C and Cao X: Regulation of toll-like
receptor signaling pathways in innate immune responses. Ann N Y
Acad Sci. 1283:67–74. 2013. View Article : Google Scholar : PubMed/NCBI
|
26
|
Mills KH: TLR-dependent T cell activation
in autoimmunity. Nat Rev Immunol. 11:807–822. 2011.PubMed/NCBI
|
27
|
Coppo R, Camilla R, Amore A, Peruzzi L,
Daprà V, Loiacono E, Vatrano S, Rollino C, Sepe V, Rampino T and
Dal Canton A: Toll-like receptor 4 expression is increased in
circulating mononuclear cells of patients with immunoglobulin A
nephropathy. Clin Exp Immunol. 159:73–81. 2010. View Article : Google Scholar : PubMed/NCBI
|
28
|
Kim GT, Cho ML, Park YE, Yoo WH, Kim JH,
Oh HJ, Kim DS, Baek SH, Lee SH, Lee JH, et al: Expression of TLR2,
TLR4 and TLR9 in dermatomyositis and polymyositis. Clin Rheumatol.
29:273–279. 2010. View Article : Google Scholar : PubMed/NCBI
|
29
|
Morgan ME, Koelink PJ, Zheng B, den Brok
MH, van de Kant HJ, Verspaget HW, Folkerts G, Adema GJ and
Kraneveld AD: Toll-like receptor 6 stimulation promotes T-helper 1
and 17 responses in gastrointestinal-associated lymphoid tissue and
modulates murine experimental colitis. Mucosal Immunol.
7:1266–1277. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Zhao C, Liao J, Chu W, Wang S, Yang T, Tao
Y and Wang G: Involvement of TLR2 and TLR4 and Th1/Th2 shift in
inflammatory responses induced by fine ambient particulate matter
in mice. Inhal Toxicol. 24:918–927. 2012. View Article : Google Scholar : PubMed/NCBI
|